ATE190624T1 - Ortsgenaue konjugatbildung zwischen immunglobulinen und nachweisbaren markierungsstoffen - Google Patents

Ortsgenaue konjugatbildung zwischen immunglobulinen und nachweisbaren markierungsstoffen

Info

Publication number
ATE190624T1
ATE190624T1 AT92902190T AT92902190T ATE190624T1 AT E190624 T1 ATE190624 T1 AT E190624T1 AT 92902190 T AT92902190 T AT 92902190T AT 92902190 T AT92902190 T AT 92902190T AT E190624 T1 ATE190624 T1 AT E190624T1
Authority
AT
Austria
Prior art keywords
immunoglobulin
immunoglobulines
derivatized
conjugates
conjugate formation
Prior art date
Application number
AT92902190T
Other languages
English (en)
Inventor
Christopher Bieniarz
Mazhar Husain
Howard E Bond
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE190624T1 publication Critical patent/ATE190624T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92902190T 1990-12-07 1991-12-02 Ortsgenaue konjugatbildung zwischen immunglobulinen und nachweisbaren markierungsstoffen ATE190624T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/624,169 US5191066A (en) 1990-12-07 1990-12-07 Site-specific conjugation of immunoglobulins and detectable labels
PCT/US1991/008971 WO1992010507A1 (en) 1990-12-07 1991-12-02 Site-specific conjugation of immunoglobulins and detectable labels

Publications (1)

Publication Number Publication Date
ATE190624T1 true ATE190624T1 (de) 2000-04-15

Family

ID=24500943

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92902190T ATE190624T1 (de) 1990-12-07 1991-12-02 Ortsgenaue konjugatbildung zwischen immunglobulinen und nachweisbaren markierungsstoffen

Country Status (12)

Country Link
US (1) US5191066A (de)
EP (1) EP0560912B1 (de)
JP (1) JP3390430B2 (de)
KR (1) KR930703347A (de)
AT (1) ATE190624T1 (de)
AU (1) AU659427B2 (de)
CA (1) CA2097920C (de)
DE (1) DE69132055T2 (de)
DK (1) DK0560912T3 (de)
ES (1) ES2146209T3 (de)
GR (1) GR3033553T3 (de)
WO (1) WO1992010507A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547833A (en) * 1994-01-04 1996-08-20 Intracel Corporation Radial flow assay, delivering member, test kit, and methods
US5561045A (en) * 1994-01-04 1996-10-01 Intracel Corporation Detection reagent, article, and immunoassay method
US5596081A (en) * 1994-03-11 1997-01-21 University Of Kentucky Research Foundation Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
WO1996010585A1 (en) * 1994-09-30 1996-04-11 Inex Pharmaceuticals Corp. Glycosylated protein-liposome conjugates and methods for their preparation
US5736624A (en) * 1994-12-02 1998-04-07 Abbott Laboratories Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents
IL116863A (en) * 1995-01-23 2000-02-17 Pasteur Sanofi Diagnostics Immunoenzymatic conjugate its preparation and use
JP4503706B2 (ja) * 1996-06-07 2010-07-14 ポニアード ファーマシューティカルズ，インコーポレイティド グリコシル化が改質されたヒト化抗体
US7569674B2 (en) * 1998-05-04 2009-08-04 Innexus Biotechnology International Limited Autophilic antibodies
US20040185039A1 (en) * 2002-08-30 2004-09-23 Heinz Kohler Therapeutic applications of noncovalent dimerizing antibodies
US20050033033A1 (en) * 1998-05-04 2005-02-10 Heinz Kohler Trans-membrane-antibody induced inhibition of apoptosis
US6218160B1 (en) * 1997-10-31 2001-04-17 Roche Diagnostics Corporation Site-specific conjugation of glycoproteins
WO1999052561A1 (en) * 1998-04-15 1999-10-21 Baxter International Inc. Inhibition of xenoreactive antibodies
US20090208418A1 (en) * 2005-04-29 2009-08-20 Innexus Biotechnology Internaltional Ltd. Superantibody synthesis and use in detection, prevention and treatment of disease
US6335155B1 (en) * 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
ATE351905T1 (de) * 1998-11-10 2007-02-15 Univ Emory Mitogene regulatoren
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
US8110665B2 (en) 2003-11-13 2012-02-07 Hanmi Holdings Co., Ltd. Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
WO2005047337A1 (en) 2003-11-13 2005-05-26 Hanmi Pharmaceutical Co., Ltd. A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
CA2606018A1 (en) * 2005-04-28 2006-11-02 Ventana Medical Systems, Inc. Nanoparticle conjugates
JP5628476B2 (ja) * 2005-04-28 2014-11-19 ベンタナ・メデイカル・システムズ・インコーポレーテツド 抗体コンジュゲート
ES2548518T3 (es) 2005-11-23 2015-10-19 Ventana Medical Systems, Inc. Conjugado molecular
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
US8609355B2 (en) 2011-07-26 2013-12-17 Indicator Systems International, Inc. Assays for the detection of microbes
WO2014127211A1 (en) 2013-02-15 2014-08-21 Research Development Foundation Deimmunized gelonin molecules and therapies
PE20160674A1 (es) 2013-08-28 2016-07-21 Stemcentrx Inc Metodos de conjugacion de anticuerpos especificos de sitio y composiciones
BR112016010169A2 (pt) 2013-11-06 2017-12-05 Stemcentrx Inc anticorpos anticlaudina e métodos de uso
PE20160993A1 (es) 2013-12-12 2016-10-14 Abbvie Stemcentrx Llc Nuevos anticuerpos anti-dpep3 y metodos de uso
WO2015127407A1 (en) 2014-02-21 2015-08-27 Stemcentrx, Inc. Anti-dll3 antibodies and drug conjugates for use in melanoma
TW201617368A (zh) 2014-09-05 2016-05-16 史坦森特瑞斯公司 新穎抗ｍｆｉ２抗體及使用方法
JP7126665B2 (ja) * 2020-05-22 2022-08-29 学校法人麻布獣医学園 アレルゲン不活化剤の評価方法及びアレルゲン不活化剤の評価キット
CN112067826B (zh) * 2020-09-15 2024-02-06 济南国科医工科技发展有限公司 基于高比活力碱性磷酸酶构建的NT-proBNP检测试剂盒及其应用
WO2026070901A1 (ja) * 2024-09-25 2026-04-02 積水メディカル株式会社 標識抗体及びその製造方法、並びに免疫学的測定試薬及び免疫学的測定方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140679A (en) * 1976-10-12 1979-02-20 Research Corporation Antigen-protein complex for blocking allergic reactions
SE427505B (sv) * 1977-03-04 1983-04-11 Pharmacia Diagnostics Ab Reagens till anvendning vid immunkemiska bestemningsmetoder
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
US4699784A (en) * 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate
FR2601679B1 (fr) * 1986-07-15 1990-05-25 Sanofi Sa Immunotoxines, procede de preparation et compositions pharmaceutiques en contenant
US4994385A (en) * 1987-10-30 1991-02-19 Abbott Laboratories Heterobifunctional coupling agents

Also Published As

Publication number Publication date
JPH06504776A (ja) 1994-06-02
ES2146209T3 (es) 2000-08-01
DE69132055D1 (de) 2000-04-20
WO1992010507A1 (en) 1992-06-25
EP0560912B1 (de) 2000-03-15
EP0560912A1 (de) 1993-09-22
AU9145291A (en) 1992-07-08
DK0560912T3 (da) 2000-07-24
GR3033553T3 (en) 2000-09-29
AU659427B2 (en) 1995-05-18
DE69132055T2 (de) 2000-10-26
CA2097920A1 (en) 1992-06-08
US5191066A (en) 1993-03-02
EP0560912A4 (en) 1996-08-28
JP3390430B2 (ja) 2003-03-24
KR930703347A (ko) 1993-11-29
CA2097920C (en) 2003-11-04

Similar Documents

Publication Publication Date Title
DE69132055D1 (de) Ortsgenaue konjugatbildung zwischen immunglobulinen und nachweisbaren markierungsstoffen
DK0897983T3 (da) Antistoffer mod CD40-L
FI914298A0 (fi) Monoklonala motkroppar foer metall- katjoner och smao molekyler.
KR850000248A (ko) 이뮤노톡신 결합체의 제조방법
RO82758A (ro) Procedeu de preparare a unor imunoglobulinei conjugate
ES2097154T3 (es) Vacuna con conjugado para streptococcus de grupo b.
ES8800603A1 (es) Un metodo para producir anticuerpos monoclonales
ATE79632T1 (de) Tumorverbundenes antigen.
BE836390A (fr) Antigene de l'hepatite a.
FR2637897B1 (fr) Dosages immunologiques de l'azt, derives et conjugues et anticorps
EP0248040A4 (de) Ricin-antikörper-konjugate.
YU46858B (sh) Postupak za dobijanje imunoglobulinskih konjugata
CA2164767A1 (en) Immunoassays for haptens and hapten tracer-antibody complex which can be used therefor, and process for the preparation thereof
IL64157A0 (en) Tridecapeptide,its preparation and its use as a hapten,tracer or antibody
DE69115938D1 (de) Monoklonaler Antikörper zur Erkennung eines Anthracyclinglycosid-spezifischen Epitopes und diesen Antikörper herstellendes Hybridoma
DE3850993D1 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.
FR2286168A1 (fr) Resines hydrocarbonees modifiees par de l'anhydride maleique
KR890701130A (ko) 안지오제닌(Angiogenin)에 대한 항체 : 면역제
BE847343A (fr) Antigene d'hepatite a,
IT1249051B (it) Immunotossina da anticorpi monoclonali anti-cd5
NO863338L (no) Fremgangsmaate for aa oeke loeseligheten av f. eks. immunokonjugatpreparater.
IL97622A (en) Monoclonal antibodies that inhibit growth of kaposi's sarcoma
DK0493686T3 (da) Monoklonale antistoffer for glycolipid-kulhydratkæder
ATE92081T1 (de) Tumorassoziiertes antigen.
SU887709A1 (ru) Безоголовочна водопропускна труба

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee